Posts

HPV Testing and Pap Test Market Gains Momentum With Evolving Screening Technologies

Image
 The hpv and pap testing market is expanding steadily as healthcare systems prioritize cervical cancer prevention, early diagnosis, and broader screening access. HPV testing helps identify high-risk human papillomavirus infections linked to cervical cancer, while Pap testing detects abnormal cervical cells that may signal precancerous changes. According to DelveInsight, the global market was valued at approximately USD 3,702.30 million in 2025 and is expected to reach USD 6,524.39 million by 2034, growing at a CAGR of 6.56% during 2026–2034. Cervical Cancer Burden Drives the HPV Testing and Pap Test Market The growing incidence of cervical cancer is an important factor contributing to the expansion of the hpv testing and pap test market . Persistent infection with oncogenic HPV types remains the primary cause of cervical cancer, while many infections may remain undetected because they do not initially produce noticeable symptoms. Regular screening therefore plays a critical role...

Prurigo Nodularis Market Expands With Targeted Therapies and Pipeline Innovation

Image
 Prurigo nodularis is a chronic inflammatory dermatological condition marked by persistent, intense itching and the development of firm, highly pruritic nodules. The disease can interfere substantially with sleep, emotional well-being, everyday activities, and overall quality of life. Growing disease recognition and the availability of targeted treatment options are transforming the prurigo nodularis therapeutics market . According to DelveInsight, the 7MM market was valued at approximately USD 1,488 million in 2025 and is expected to reach nearly USD 4,433 million by 2034, expanding at a CAGR of 12.90% between 2025 and 2034. The analysis covers the United States, EU4, the United Kingdom, and Japan, with detailed assessment of epidemiology, treatment practices, marketed therapies, emerging drugs, and future commercial opportunities. Prurigo Nodularis Disease Burden and Increasing Clinical Recognition Prurigo nodularis develops through a persistent itch-scratch cycle in which repeat...

Structural Heart Devices Market Set for Strong Growth Through Innovation and Regional Expansion

Image
 The structural heart devices market is experiencing significant momentum as the prevalence of valvular, congenital, and other structural cardiac disorders continues to rise worldwide. According to DelveInsight, the market was valued at USD 12.94 billion in 2025 and is expected to reach USD 30.62 billion by 2034, expanding at a CAGR of 10.08% from 2026 to 2034. Increasing adoption of catheter-based interventions, technological innovation, demand for shorter recovery periods, and broader treatment eligibility are among the major factors supporting this growth. Structural Heart Devices Market: Rising Cardiovascular Disease Burden The increasing incidence of structural and valvular heart conditions is creating a substantial need for advanced cardiac devices. Aortic valve stenosis affects an estimated 9 million people globally, while mitral regurgitation impacts nearly 24 million individuals. Congenital conditions, including atrial septal defects, ventricular septal defects, and pat...